By Devika Patel
Knoxville, Tenn., Dec. 16 - OncoMethylome Sciences SA said it arranged a €8.4 million private placement of shares.
The company sold 1,332,877 shares.
Settlement is expected Dec. 18.
Proceeds will be used to expand OncoMethylome's biomarker development for pharmaceutical applications, such as companion diagnostic tests used in personalized treatment of cancer patients.
Based in Liege, Belgium, OncoMethylome Sciences is a molecular diagnostics company.
| Issuer: | OncoMethylome Sciences SA
|
| Issue: | Shares
|
| Amount: | €8.4 million
|
| Shares: | 1,332,877
|
| Warrants: | No
|
| Pricing date: | Dec. 16
|
| Settlement date: | Dec. 18
|
| Stock symbol: | Pink Sheets: ONCMF
|
| Stock price: | $11.295 at close Dec. 15
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
